ACTEMRA (R) (tocilizumab) Significantly Reduced Signs And Symptoms Of Rheumatoid Arthritis In Patients Who Failed Prior Treatments

Data from two Phase III studies showed that patients who suffer from the debilitating and painful effects of rheumatoid arthritis (RA) achieved significant improvements in signs and symptoms when treated with ACTEMRA(R) (tocilizumab) alone or in combination with methotrexate compared with methotrexate alone.